Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Aug 28:25:100641.
doi: 10.1016/j.ymgmr.2020.100641. eCollection 2020 Dec.

Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation

Affiliations
Case Reports

Ethylmalonic encephalopathy: Clinical course and therapy response in an uncommon mild case with a severe ETHE1 mutation

Melike Ersoy et al. Mol Genet Metab Rep. .

Abstract

Ethylmalonic encephalopathy (EE) is a rare metabolic disorder caused by dysfunction of ETHE1 protein, a mitochondrial dioxygenase involved in hydrogen sulfide (H2S) detoxification. EE is usually a fatal disease with a severe clinical course mainly associated with developmental delay and regression, recurrent petechiae, orthostatic acrocyanosis, and chronic diarrhoea. Treatment includes antioxidants, antibiotics that lower H2S levels and antispastic medications, which are not curative. The mutations causing absence of the ETHE1 protein, as is the case for the described patient, usually entail a severe fatal phenotype. Although there are rare reported cases with mild clinical findings, the mechanism leading to these milder cases is also unclear. Here, we describe an 11-year-old boy with an ETHE1 gene mutation who has no neurocognitive impairment but chronic diarrhoea, which is controlled by oral medical treatment, and progressive spastic paraparesis that responded to Achilles tendon lengthening.

Keywords: 3-MST, 3-mercaptopyruvate sulfurtransferase; CAT, cysteine aminotransferase; CBS, cystathionine β-synthase; CSE, cystathionine γ-lyase; EE, ethylmalonic encephalopathy; EMA, ethylmalonic acid; ETHE1 gene; GSH, glutathione; H2S; H2S, hydrogen sulfide; H2SO3, persulfide; MTZ, metronidazole; Mild course; NAC, N-acetylcysteine; SCAD, short-chain acyl-CoA dehydrogenase; SDO, sulfur dioxygenase; SQR, sulfide quinone oxidoreductase; SUOX, sulfite oxidase; TST, thiosulfate sulfur transferase; Therapy response; UQ, quinone; cIII, complex III; cIV, complex IV.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests to declare.

Figures

Fig. 1
Fig. 1
The pathways of H2S synthesis and removal (CBS: cystathionine β-synthase; CSE: cystathionine γ-lyase; CAT: cysteine aminotransferase; 3-MST: 3-mercaptopyruvate sulfurtransferase; SQR: sulfide quinone oxidoreductase; SDO/ETHE1: sulfur dioxygenase; SUOX: sulfite oxidase; TST: thiosulfate sulfur transferase; GSH: glutathione; UQ: quinone; cIII: complex III; cIV: complex IV).
Fig. 2
Fig. 2
Virtual absence of ETHE1 protein in the case according to western blotting.

Similar articles

Cited by

References

    1. Chen X., Han L., Yao H. Novel compound heterozygous variants of ETHE1 causing ethylmalonic encephalopathy in a Chinese patient: A case report. Front. Genet. 2020;11:341. doi: 10.3389/fgene.2020.00341. - DOI - PMC - PubMed
    1. Tavasoli A.Z., Rostami P., Ashrafi M.R., Karımzadeh P. Neurological and vascular manifestations of ethylmalonic encephalopathy. Iran J. Child Neurol. 2017;11:57–60. - PMC - PubMed
    1. Pigeon N., Campeau P.M., Cyr D., Lemieux B., Clarke J.T.R. Clinical heterogeneity in ethylmalonic encephalopathy. J. Child Neurol. 2009;24:991–996. doi: 10.1177/0883073808331359. - DOI - PubMed
    1. Tiranti V., D’Adamo P., Briem E., Ferrari G., Mineri R., Lamantea E., Mandel H., Balestri P., Garcia-Silva M.T., Vollmer B., Rinaldo P., Hahn S.H., Leonard J., Rahman S., Dionisi-Vici C., Garavaglia B., Gasparini P., Zeviani M. Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am. J. Hum. Genet. 2004;74:239–252. doi: 10.1086/381653. - DOI - PMC - PubMed
    1. Tiranti V. ETHE1 mutations are specific to ethylmalonic encephalopathy. J. Med. Genet. 2006;43:340–346. doi: 10.1136/jmg.2005.036210. - DOI - PMC - PubMed

Publication types